A clinical trial of herbal compound MA-305 in patients with mild to moderate hypertension: A Pilot Study.

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2010/091/000418

Enrollment

Registered

2010-09-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Cardimap (MA 305: A herbal formulation developed by Maharishi Ayurveda to arrest, abate and control hypertension. It is presented in the form of tablet and contains the following herba

Eligibility

Inclusion criteria

Inclusion criteria: 1.. Patients who are willing to participate in the study. `2 . Aged 18 to 70 yrs. `3. Primary hypertensive patients. `4. Patients with pre hypert ensive ( SBP: 120-130, DBP: 80-89) and stage 1( SBP:140-159, DBP: 90-99) (According to JNC 7 criteria). ``5. patients with stable blood pressure and with no significant change in their therapy over the last 4 ``weeks prior to entry into the study.

Exclusion criteria

Exclusion criteria: (a) Patients unwilling to participate. (b) Pregnancy and breast-feeding. (c) Concomitant severe diseases. (d) Uncontrolled hypertension.

Design outcomes

Primary

Measure	Time frame
The aim of study is to evaluate the efficacy and tolerability of herbal compound MA ?305 in patients with mild to moderate hypertension.Timepoint:	—

Secondary

Measure	Time frame
NOTimepoint:	—

Countries

India

Contacts

Public ContactMr. S. M. Bhushan,M.pharmacology and M.Pharmaceutics,Dip. bact Director Reseach

randeepg@hotmail.com011-26593676 (O),011-26198654, (R)

Outcome results